Haplo
Evaluation of efficacy, outcomes and safety of CD45RO+ memory T cell add-back following haematopoietic cell transplantation in paediatric patients with primary immunodeficiency disorder.
- Study stage: Set-up
- Sponsor: Newcastle upon Tyne Hospital
- Funder: NIHR EME
- Therapeutic area: Blood
Type of study: CTIMP